We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 2.04% | 12.50 | 12.00 | 13.00 | 13.00 | 12.25 | 12.25 | 1,224,973 | 15:54:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -1.50 | 32.57M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/10/2022 10:21 | I'm not quite sure why you have said that ........ Only FDA cleared ... can tweak in simple talk .....Have you sold out or something :-) | amaretto1 | |
16/10/2022 10:19 | Thanks goosed. Certainly one to think about. | bagpuss67 | |
16/10/2022 10:12 | It's a huge benefit for AGL ....Because odviously we have a system that covers 100s of different Cancers. Ovarian been the latest success. Other companies still have to go and apply for FDA approval the closest to this is at least 3 years away .. start to finish ....Then they can starting tweaking like AGL can do now.It's actually a very simplistic read !!! | amaretto1 | |
16/10/2022 09:58 | That is a question perhaps best answered by IR @ Angle but my guess would be that as the above paragraph alludes to, any test with FDA clearance clears the way for subsequent IVD application. Not perhaps unlike how FDA approval gives way to 510k application/approval process - necessary but nowhere near as cumbersome, time consuming & expensive. Just imho though & happy to be corrected. | gooosed | |
16/10/2022 09:52 | But would increased FDA oversight of LDT adversely impact AGL? | bagpuss67 | |
16/10/2022 09:48 | "The VALID act, a bipartisan bill that could close the legal loophole within the FDA’s medical device regulations that allowed disgraced startup Theranos to market and sell fraudulent tests, could finally be headed towards a resolution." "Technology certification review is a new approach that will allow IVD developers to submit a single representative test for FDA approval. If the FDA approves the developer’s design and clinical validity and the test gets to market, the developer would be able to make test tweaks and develop new ones that rely on the same underlying technology. “The goal is to allow for flexibility,” says Richardson. If a high-quality developer has already demonstrated to the FDA that it can meet those standards, then technology certification allows continued innovation and test development to meet patient need without having to return to the agency for review, she adds. “This has been proposed because diagnostics have a much more rapid cycle of innovation and modification compared to other devices,” says Richardson. “It allows a developer to adjust a test or develop a new test based on emerging research.” | gooosed | |
16/10/2022 08:58 | Mimi me, this has dropped from 160p last year and continues to drop fact.Investors adage - Sell on rumours buy on facts. The only fact is PI are selling. | 1liam | |
16/10/2022 06:31 | Is anyone up to speed on the US VALID Act and its potential implications for AGL? | bagpuss67 | |
15/10/2022 19:47 | I no trust you. You lie a lot | 1liiam | |
15/10/2022 11:20 | I wouldn't Truss the BODs. This has more failings than Kwasi Kwarteng.ALARM BELLS ARE RINGING !!! | 1liam | |
15/10/2022 08:58 | ASDB9. What an articulate fellow you are. | tday | |
15/10/2022 00:33 | Defo a rollover at that timing and spread | tburns | |
14/10/2022 17:53 | More chance of winning Lotto EURO Rollover then this staying at this level. Reiterated Sell Buy Target 20p | 1liam | |
14/10/2022 17:36 | It was a roll over ...Some one imo is playing games with this share ....I'm convinced we are being lined up for a bid ....And it won't be anything like future value .....Bid in the nuts .... it will be American useing the strong dollar....Certain of it !!! | amaretto1 | |
14/10/2022 16:46 | Andrew Holder does answer awkward questions, to the exclusion of phuckwits, unfortunate for Tday | asdb9 | |
14/10/2022 15:45 | 250k sell at 53p. Seller still out there. One day they will stop. JupiterAsset2.0 | purchaseatthetop | |
14/10/2022 15:43 | Dean, AN has around 7m shares, it's in his interest to get shareholder value. | stevelauren23 | |
14/10/2022 15:21 | SYME looks like a good punt. | 1liam | |
14/10/2022 15:12 | There are lots of ways to make an omelette. Quite possible to do a global strategic partnership and leave them to focus on the science and getting approvals and the partner with roll out and commercialisation | waterloo01 | |
14/10/2022 15:09 | Rampers giving up trying to flog this dead horse on the other board.Reiterated SellBuy target 20pALARM BELLS ARE RINGING !!! | 1liam | |
14/10/2022 14:51 | Another one of Purchaseatthetop blinding buys..... NotReiterated sell. | 1liam | |
14/10/2022 14:50 | Pikey Gypsy LIAM must be on a break from interviews at the job centre near Jaywick where he lives with his brother BELLEND, sorry HALLAND. Poor lads. | antonagis | |
14/10/2022 14:48 | Why keep lying? | 1liiam | |
14/10/2022 14:47 | You really silly | 1liiam |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions